👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Andrew Wirth
Oncology
English
10,885+
Patients seen
16
Years in practice
8
Publications
1
Languages spoken
About
Dr Andrew Wirth is a highly esteemed Oncologist. Dr Wirth graduated medicine at the University of Melbourne in 1981. After completing training in medical and radiation oncology, Dr Wirth was appointed consultant radiation oncologist. Dr Wirth completed their MD Thesis on “The role of radiotherapy and imaging in the management of haematological malignancies” through the University of Melbourne in 2009.
Dr Wirth has expertise in a range of areas within oncology. Dr Wirth has a particular interest in the management of haematological, thoracic and CNS malignancies.
Dr Wirth is actively involved in research, with a focus on radiotherapy for initial and salvage therapy for a range of lymphomas and the use of PET scanning for staging and response assessment in lymphomas. They have been a lead investigator on national clinical trials and an International Extra-nodal Lymphoma Study Group study.
Dr Wirth is a respected leader in the field of oncology. They are an editorial board member for Leukemia and Lymphoma and have been a member of the UICC TNM Expert Advisory Panel on Lymphoma and on the scientific advisory committee for aggressive lymphomas of the Australasian Leukaemia and Lymphoma Group. They have served on State and National guidelines committees for lymphoma and are a founding member of the International Lymphoma Radiation Oncology Group.
Dr Wirth has expertise in a range of areas within oncology. Dr Wirth has a particular interest in the management of haematological, thoracic and CNS malignancies.
Dr Wirth is actively involved in research, with a focus on radiotherapy for initial and salvage therapy for a range of lymphomas and the use of PET scanning for staging and response assessment in lymphomas. They have been a lead investigator on national clinical trials and an International Extra-nodal Lymphoma Study Group study.
Dr Wirth is a respected leader in the field of oncology. They are an editorial board member for Leukemia and Lymphoma and have been a member of the UICC TNM Expert Advisory Panel on Lymphoma and on the scientific advisory committee for aggressive lymphomas of the Australasian Leukaemia and Lymphoma Group. They have served on State and National guidelines committees for lymphoma and are a founding member of the International Lymphoma Radiation Oncology Group.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Andrew Wirth
Education & training
-
2000–2006 MD · Medicine and Surgery
-
2006–2010 Residency · Oncology
-
2010–2011 Fellowship · Subspecialty training
Career & appointments
-
2010-09–2011-08 Junior consultant
Licenses & insurance
Medical licenses
— Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
HDI Global · 2,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 453 |
| Annual physical exam | 99395 | 1,275 |
| Vaccination administration | 90471 | 2,075 |
| Minor procedure (skin) | 17110 | 724 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 180.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 450.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 11 · i10: 4
-
European registry analysis of Oncology outcomes
DOI: 10.7570/euroclin.2025.0 · PMID: 33452545 · cited by 117
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.2823/euroclin.2024.1 · PMID: 31936237 · cited by 135
-
European registry analysis of Oncology outcomes
DOI: 10.7278/euroclin.2023.2 · PMID: 35734800 · cited by 41
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2011
- national college of family doctors — Member · since 2011
- European Union of Medical Specialists (UEMS) — Member · since 2011
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · andrew.wirth@euroclinics.example
